Sectoral Asset Management as of March 31, 2015
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 77 positions in its portfolio as reported in the March 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Biogen Idec (BIIB) | 8.0 | $210M | 498k | 422.24 | |
BioMarin Pharmaceutical (BMRN) | 6.7 | $176M | 1.4M | 124.62 | |
Celgene Corporation | 5.3 | $139M | 1.2M | 115.28 | |
Gilead Sciences (GILD) | 4.9 | $130M | 1.3M | 98.13 | |
Incyte Corporation (INCY) | 4.7 | $123M | 1.3M | 91.66 | |
Actavis | 4.2 | $111M | 374k | 297.62 | |
Amgen (AMGN) | 4.0 | $106M | 664k | 159.85 | |
Teva Pharmaceutical Industries (TEVA) | 3.9 | $104M | 1.7M | 62.30 | |
Thermo Fisher Scientific (TMO) | 3.0 | $79M | 587k | 134.34 | |
Mylan Nv | 2.7 | $72M | 1.2M | 59.35 | |
Alexion Pharmaceuticals | 2.6 | $69M | 396k | 173.30 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.3 | $60M | 510k | 117.97 | |
Shire | 2.3 | $60M | 249k | 239.29 | |
Amicus Therapeutics (FOLD) | 2.1 | $54M | 5.0M | 10.88 | |
Halozyme Therapeutics (HALO) | 2.0 | $53M | 3.7M | 14.28 | |
Dr. Reddy's Laboratories (RDY) | 2.0 | $53M | 929k | 57.10 | |
Pfizer (PFE) | 2.0 | $52M | 1.5M | 34.79 | |
Keryx Biopharmaceuticals | 1.9 | $49M | 3.8M | 12.73 | |
Intercept Pharmaceuticals In | 1.8 | $47M | 165k | 282.02 | |
Ptc Therapeutics I (PTCT) | 1.7 | $46M | 753k | 60.85 | |
Seattle Genetics | 1.7 | $45M | 1.3M | 35.35 | |
Perrigo Company (PRGO) | 1.7 | $45M | 269k | 165.55 | |
Portola Pharmaceuticals | 1.7 | $44M | 1.2M | 37.96 | |
Mallinckrodt Pub | 1.6 | $44M | 343k | 126.65 | |
Oncomed Pharmaceuticals | 1.5 | $40M | 1.5M | 25.78 | |
Synageva Biopharma | 1.4 | $36M | 366k | 97.53 | |
Medtronic (MDT) | 1.2 | $32M | 408k | 77.99 | |
Achillion Pharmaceuticals | 1.2 | $32M | 3.2M | 9.86 | |
Alder Biopharmaceuticals | 1.2 | $31M | 1.1M | 28.86 | |
United Therapeutics Corporation (UTHR) | 1.1 | $30M | 175k | 172.44 | |
Relypsa | 1.1 | $30M | 838k | 36.07 | |
Sagent Pharmaceuticals | 1.0 | $27M | 1.2M | 23.25 | |
Medivation | 1.0 | $27M | 209k | 129.07 | |
Dex (DXCM) | 0.9 | $25M | 400k | 62.34 | |
Momenta Pharmaceuticals | 0.9 | $24M | 1.6M | 15.20 | |
Align Technology (ALGN) | 0.9 | $23M | 433k | 53.78 | |
Acceleron Pharma | 0.9 | $23M | 599k | 38.06 | |
Abbott Laboratories (ABT) | 0.8 | $22M | 484k | 46.33 | |
Akorn | 0.8 | $22M | 467k | 47.51 | |
Tetraphase Pharmaceuticals | 0.8 | $22M | 605k | 36.64 | |
Karyopharm Therapeutics (KPTI) | 0.8 | $22M | 707k | 30.61 | |
Clovis Oncology | 0.7 | $19M | 249k | 74.23 | |
Intuitive Surgical (ISRG) | 0.6 | $15M | 30k | 505.02 | |
NxStage Medical | 0.6 | $15M | 876k | 17.30 | |
Invitae (NVTAQ) | 0.6 | $15M | 874k | 16.76 | |
HeartWare International | 0.5 | $14M | 154k | 87.77 | |
Hca Holdings (HCA) | 0.5 | $13M | 167k | 75.23 | |
Ascendis Pharma A S (ASND) | 0.5 | $13M | 732k | 17.35 | |
Novartis (NVS) | 0.5 | $12M | 119k | 98.61 | |
Amphastar Pharmaceuticals (AMPH) | 0.4 | $11M | 734k | 14.96 | |
Novo Nordisk A/S (NVO) | 0.4 | $10M | 195k | 53.39 | |
CIGNA Corporation | 0.4 | $9.9M | 77k | 129.44 | |
Zs Pharma | 0.3 | $9.2M | 219k | 42.08 | |
Universal Health Services (UHS) | 0.3 | $7.8M | 66k | 117.71 | |
Tg Therapeutics (TGTX) | 0.3 | $6.8M | 436k | 15.48 | |
Accuray Incorporated (ARAY) | 0.1 | $2.1M | 227k | 9.30 | |
Advaxis | 0.1 | $2.2M | 151k | 14.44 | |
Lannett Company | 0.1 | $1.7M | 26k | 67.72 | |
Impax Laboratories | 0.1 | $1.9M | 40k | 46.88 | |
McKesson Corporation (MCK) | 0.1 | $1.6M | 7.0k | 226.16 | |
WuXi PharmaTech | 0.1 | $1.6M | 41k | 38.79 | |
Valeant Pharmaceuticals Int | 0.1 | $1.6M | 8.1k | 198.62 | |
Jazz Pharmaceuticals (JAZZ) | 0.1 | $1.6M | 9.4k | 172.78 | |
Endo International | 0.1 | $1.7M | 19k | 89.68 | |
Auris Med Hldg | 0.1 | $1.5M | 280k | 5.35 | |
DepoMed | 0.1 | $1.2M | 55k | 22.40 | |
Pacira Pharmaceuticals (PCRX) | 0.1 | $1.2M | 14k | 88.82 | |
Alkermes (ALKS) | 0.1 | $1.4M | 23k | 60.96 | |
Tandem Diabetes Care | 0.1 | $1.4M | 111k | 12.62 | |
Horizon Pharma | 0.1 | $1.3M | 52k | 25.97 | |
Immune Design | 0.1 | $1.4M | 67k | 21.11 | |
Eleven Biotherapeutics | 0.0 | $1.0M | 113k | 8.92 | |
Eagle Pharmaceuticals (EGRX) | 0.0 | $927k | 22k | 41.90 | |
Nektar Therapeutics (NKTR) | 0.0 | $870k | 79k | 11.00 | |
Cambrex Corporation | 0.0 | $463k | 12k | 39.66 | |
Catalent | 0.0 | $445k | 14k | 31.13 | |
Coherus Biosciences (CHRS) | 0.0 | $387k | 13k | 30.58 |